Beckman coulter receives fda clearance for dxc 500 au chemistry analyzer, expanding portfolio with proven six sigma performance

Anaheim, calif. , july 25, 2023 /prnewswire/ -- beckman coulter diagnostics, a clinical diagnostics leader, received fda clearance for its new dxc 500 au chemistry analyzer, an automated chemistry analyzer, expanding the company's clinical chemistry offering and demonstrating ongoing commitment to product innovation in the in vitro diagnostic industry.
DHR Ratings Summary
DHR Quant Ranking